A severe case of COVID-19 or influenza could increase the risk of lung cancer later on, according to new research. Scientists ...

Flu has overtaken covid in infections and hospitalizations during the winter respiratory virus season, and their virulence is ...

Flu is outpacing Covid in the U.S. for the second consecutive winter, raising questions about America’s future with the ...

Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease's development, but vaccination heads off those harmful effects, new research from UVA Health's Beirne ...

Severe COVID-19 raises lung cancer risk by 24%, study of 76 million Americans finds In A Nutshell People hospitalized with severe COVID-19 had roughly a 24 percent higher risk of developing lung ...

Learn how severe respiratory illness leaves the lungs vulnerable to cancer, and how vaccines could prevent these vulnerabilities.

Stanford researchers develop breakthrough nasal spray vaccine that could potentially protect against a variety of infections, like COVID-19 and pneumonia, for several months.

In issuing a positive recommendation, the EMA has diverged from the FDA, which has set higher approval standards for ...

Human metapneumovirus, or HMPV, typically spreads during winter and spring.

A UVA Health study finds severe viral infections can prime the lungs for cancer, but vaccination appears to reduce that risk.

In a new study, researchers found that being hospitalized for flu or COVID-19 was linked to a 24 percent increase in later lung cancer risk. Learn how to protect yourself.

Severe COVID or flu may quietly raise lung cancer risk—but vaccines appear to stop the damage before it starts.